EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische Studie

Effect of Personalized Risk Messages on Uptake of Colorectal Cancer Screening

Peter H Schwartz iD, Susan M Perkins iD, Susan M Rawl iD, Karen K Schmidt iD, Sandra Althouse, Thomas F Imperiale iD

Annals of Internal Medicine · 2025

DOI: 10.7326/annals-24-03144 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Annals of Internal Medicine, 2025. Verfasst von Peter H Schwartz und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Indiana University School of Medicine; Indiana University Center for Bioethics; and Department of Philosophy, Indiana Univers…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Early Detection of Cancer, Decision Support Techniques, Patient Education as Topic. Die Arbeit nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Providing personalized risk information to patients and their providers could improve colorectal cancer (CRC) screening. OBJECTIVE: To determine whether providing information on patient risk for advanced colorectal neoplasia (ACN; which includes CRC and advanced precancerous lesions) to patients and providers affects screening uptake, and to identify effect moderators. DESIGN: Randomized controlled trial (2 × 2 factorial design). (ClinicalTrials.gov: NCT04683731). SETTING: Primary care clinics in 2 health care systems. PARTICIPANTS: 214 providers and 1084 average-risk patients due for screening. INTERVENTION: Participants were randomly assigned to view a CRC screening decision aid with or without a personalized message about ACN risk. Providers were randomly assigned to receive notifications that the patient was due for screening, with or without a personalized message about the patient's ACN risk. MEASUREMENTS: Screening test completion by 6 months. Logistic regression was used to estimate intervention effects. RESULTS: Overall, there were no differences in screening uptake or test completion for the provider notification (predicted probabilities, 41.5% vs. 36.4% for personalized vs. generic; difference, 5.1 [95% CI, -1.6 to 11.8] percentage points) or decision aid (predicted probabilities, 36.8% vs. 41.0% for personalized vs. generic; difference, -4.1 [CI, -10.2 to 1.9] percentage points) interventions. Health system was an effect moderator for stool testing. For one health system, the stool testing rate was higher for personalized versus generic provider notification (predicted probabilities, 21.1% vs. 7.9%; difference, 13.2 [CI, 1.6 to 24.8] percentage points) when the decision aid was generic. The stool testing rate was higher for the personalized versus the generic decision aid (predicted probabilities, 21.4% vs. 7.9%; difference, 13.5 [CI, 2.4 to 24.5] percentage points) when the provider notification was generic. LIMITATIONS: Few participants had high-average ACN risk. Non-English-speaking patients were excluded. CONCLUSION: Although including personalized risk for ACN in a decision aid or provider notification had no overall effect, it increased uptake of stool testing in one health system. PRIMARY FUNDING SOURCE: Patient-Centered Outcomes Research Institute (PCORI).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsEarly Detection of CancerDecision Support TechniquesPatient Education as TopicHumansMaleFemaleMiddle AgedAgedRisk AssessmentColonoscopy

Autor:innen und Institutionen

  • Department of Medicine, Indiana University School of Medicine; Indiana University Center for Bioethics; and Department of Philosophy, Indiana University School of Liberal Arts, Indianapolis, Indiana (P.H.S.).
  • Department of Biostatistics and Health Data Science, Indiana University School of Medicine, and Department of Biostatistics and Health Data Science, Indiana University Richard M. Fairbanks School of Public Health, India…
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center and Indiana University School of Nursing, Indianapolis, Indiana (S.M.R.).
  • Department of Medicine, Indiana University School of Medicine, and Indiana University Center for Bioethics, Indianapolis, Indiana (K.K.S.).
  • Department of Biostatistics and Health Data Science, Indiana University School of Medicine, Indianapolis, Indiana (S.A.).
  • Department of Medicine, Indiana University School of Medicine; Indiana University Melvin and Bren Simon Comprehensive Cancer Center; and Regenstrief Institute, Inc., Indianapolis, Indiana (T.F.I.).

ORCID-Profile: Peter H Schwartz, Susan M Perkins, Susan M Rawl, Karen K Schmidt, Thomas F Imperiale

Zitieren

APA

Schwartz, P. H., Perkins, S. M., Rawl, S. M., Schmidt, K. K., Althouse, S., & Imperiale, T. F. (2025). Effect of Personalized Risk Messages on Uptake of Colorectal Cancer Screening. Annals of Internal Medicine. https://doi.org/10.7326/annals-24-03144

Vancouver

Schwartz PH, Perkins SM, Rawl SM, Schmidt KK, Althouse S, Imperiale TF. Effect of Personalized Risk Messages on Uptake of Colorectal Cancer Screening. Annals of Internal Medicine. 2025. doi:10.7326/annals-24-03144

BibTeX
@article{Schwartz2025,
  author = {Schwartz, Peter H and Perkins, Susan M and Rawl, Susan M and Schmidt, Karen K and Althouse, Sandra and Imperiale, Thomas F},
  title = {Effect of Personalized Risk Messages on Uptake of Colorectal Cancer Screening},
  journal = {Annals of Internal Medicine},
  year = {2025},
  doi = {10.7326/annals-24-03144}
}
Kostenlos starten →